Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""McCleary-Wheeler, Angela L."" wg kryterium: Autor


Tytuł :
Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination
Autorzy :
Carr, Ryan M.
Pokaż więcej
Źródło :
In Pancreatology September 2020 20(6):1115-1122
Czasopismo naukowe
Tytuł :
Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination.
Autorzy :
Carr RM; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA; Department of Medical Oncology, Department of Oncology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55902, USA.
Duma N; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin, Madison, WI, USA.
McCleary-Wheeler AL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Almada LL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Marks DL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Graham RP; Department of Laboratory Medicine Pathology, Mayo Clinic, Rochester, MN, USA.
Smyrk TC; Department of Laboratory Medicine Pathology, Mayo Clinic, Rochester, MN, USA.
Lowe V; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Borad MJ; Division of Hematology-Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.
Kim G; Division of Hematology-Oncology, The George Washington University, Washington, DC, USA.
Johnson GB; Division of Nuclear Medicine, Mayo Clinic, Rochester, MN, USA.
Allred JB; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Yin J; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Lim VS; Department of Medical Oncology, Department of Oncology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55902, USA.
Bekaii-Saab T; Division of Hematology-Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.
Ma WW; Department of Medical Oncology, Department of Oncology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55902, USA.
Erlichman C; Department of Medical Oncology, Department of Oncology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55902, USA.
Adjei AA; Department of Medical Oncology, Department of Oncology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55902, USA. Electronic address: .
Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA; Department of Medical Oncology, Department of Oncology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55902, USA. Electronic address: .
Pokaż więcej
Źródło :
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] [Pancreatology] 2020 Sep; Vol. 20 (6), pp. 1115-1122. Date of Electronic Publication: 2020 Jul 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
TFII-I-mediated polymerase pausing antagonizes GLI2 induction by TGFβ.
Autorzy :
McCleary-Wheeler AL; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, USA.
Paradise BD; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, USA.
Almada LL; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
Carlson AJ; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
Marks DL; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
Vrabel A; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
Vera RE; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
Sigafoos AN; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
Olson RL; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2020 Jul 27; Vol. 48 (13), pp. 7169-7181.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Nuclear Proteins/*metabolism
RNA Polymerase II/*metabolism
Transcription Factors, TFII/*physiology
Transforming Growth Factor beta/*metabolism
Zinc Finger Protein Gli2/*metabolism
Hep G2 Cells ; Humans ; Promoter Regions, Genetic ; Repressor Proteins/physiology ; Transcription, Genetic ; Transcriptional Activation
Czasopismo naukowe
Tytuł :
Evaluation of canonical Hedgehog signaling pathway inhibition in canine osteosarcoma.
Autorzy :
Baldanza VE; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, United of States America.
Rogic A; Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, United of States America.
Yan W; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, United of States America.
Levine CB; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, United of States America.
Levine RA; Department of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, New York, United of States America.
Miller AD; Department of Biomedical Sciences, Section of Anatomic Pathology, College of Veterinary Medicine, Cornell University, Ithaca, New York, United of States America.
McCleary-Wheeler AL; Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, United of States America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Apr 29; Vol. 15 (4), pp. e0231762. Date of Electronic Publication: 2020 Apr 29 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anilides/*pharmacology
Bone Neoplasms/*pathology
Hedgehog Proteins/*metabolism
Osteosarcoma/*pathology
Pyridines/*pharmacology
Signal Transduction/*drug effects
Anilides/therapeutic use ; Animals ; Apoptosis/drug effects ; Bone Neoplasms/drug therapy ; Bone Neoplasms/veterinary ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Dogs ; Gene Expression Profiling ; Hedgehog Proteins/genetics ; Osteosarcoma/drug therapy ; Osteosarcoma/veterinary ; Pyridines/therapeutic use ; RNA, Messenger/isolation & purification ; RNA, Messenger/metabolism ; Smoothened Receptor/antagonists & inhibitors ; Smoothened Receptor/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies